Industry Sponsored Symposium - Managing Eosinophilic Esophagitis: Take the Case Challenge

Evan S. Dellon, MD, MPH, FACG; Gary W. Falk, MD, MS, MACG; Amanda Muir, MD, MTR

This activity is supported by Takeda Pharmaceuticals U.S.A., Inc.

Patients with eosinophilic esophagitis (EoE) frequently experience extensive delays in the diagnosis of their disease, often suffering for years with debilitating symptoms. Until recently, there were no FDA approved treatments for EoE. That changed recently with the approval of 2 new therapies, 1 topical and 1 systemic. In this interactive, case-based symposium, expert faculty will review the latest evidence for new and emerging treatments for EoE. Clinical cases will provide context and instruction for the stepwise approach to EoE diagnosis and selecting therapies based on the latest data and clinical guidelines.

Industry-Sponsored Satellite Symposia provide additional educational opportunities for attendees. These programs are independent of the ACG 2024 Annual Scientific Meeting and Postgraduate Course programs. The ACG is not the continuing medical education provider of these programs. For more information, see the company sponsor.

Use the Register button or register at link www.medscape.org/symposium/eoe-2024